- Home
- QRVO vs CAI Comparison
QRVO vs CAI Comparison
Compare QRVO & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QRVO | CAI |
|---|---|---|
| Founded | 1957 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 6.0B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | QRVO | CAI |
|---|---|---|
| Price | $78.24 | $18.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $90.55 | $33.67 |
| AVG Volume (30 Days) | 1.1M | ★ 2.0M |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 180.56 | N/A |
| EPS | ★ 3.30 | N/A |
| Revenue | ★ $3,718,971,000.00 | N/A |
| Revenue This Year | $0.81 | $24.26 |
| Revenue Next Year | N/A | $22.60 |
| P/E Ratio | $23.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $49.46 | $17.15 |
| 52 Week High | $106.29 | $42.50 |
Technical Indicators
Market Signals| Indicator | QRVO | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.73 | 36.95 |
| Support Level | $75.71 | $17.15 |
| Resistance Level | $79.13 | $21.47 |
| Average True Range (ATR) | 1.87 | 1.04 |
| MACD | -0.32 | 0.07 |
| Stochastic Oscillator | 30.18 | 22.34 |
Price Performance
Historical ComparisonAbout QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.